Related Experiment Video
Updated: Mar 25, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart Failure: Overcoming the Physiologic Dilemma Through Evidence-Based Practice
Sheila Melander1, Stephen Miller2
1Norton's Healthcare System, University of Kentucky, 3682 Briarcliff Trace, Owensboro, KY 42303, USA.
Recent advancements in heart failure (HF) treatments improve survival and quality of life. However, older patients with comorbidities require customized care due to limited trial data and risks of adverse drug interactions.
Area of Science:
- Cardiology
- Geriatric Medicine
- Pharmacology
Background:
- Heart failure (HF) treatment has advanced, improving outcomes.
- The majority of HF patients are over 65 years old.
- Older adults often have multiple comorbidities and are underrepresented in clinical trials.
Purpose of the Study:
- To highlight the need for customized treatment strategies for older heart failure patients.
- To emphasize the risks associated with polypharmacy in this population.
Main Methods:
- Review of current treatment guidelines and clinical trial data.
- Analysis of challenges in applying evidence to older adults with multiple comorbidities.
Main Results:
- Improved survival and quality of life are observed with modern HF therapies.
- Limited evidence exists for the optimal management of elderly HF patients with complex conditions.
- Older patients with multiple comorbidities and polypharmacy face high risks of adverse events and drug interactions.
Conclusions:
- Therapeutic approaches for heart failure in older adults require personalization.
- Healthcare providers must carefully manage polypharmacy to mitigate risks in elderly HF patients.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology

